Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
5
×
boston top stories
clinical trials
fda
5
×
life sciences
national blog main
biotech
national top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alexion pharmaceuticals
avexis
boston
cancer
cancer immunotherapy
drugs
geoffrey porges
medical device
nonalcoholic steatohepatitis
regeneron pharmaceuticals
What
disease
5
×
drug
medicines
nash
news
pharma
pharmaceuticals
roundup
according
akcea
alternative
american
approved
ash
autoimmune
big
bio
biotech
blood
candidate
cases
caught
causing
centers
cigarettes
companies
control
country
deal
deaths
dicerna
diego
digital
electronic
epidemic
expensive
eye
fatty
fda
frenzied
Language
unset
Current search:
disease
×
" boston blog main "
×
fda
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
ASH 2018: Three Up, Two Down As The Big Blood Disease Meeting Rolls On